{"id":11289,"date":"2018-08-26T05:00:47","date_gmt":"2018-08-26T09:00:47","guid":{"rendered":"https:\/\/medicarereport.org\/?p=11289"},"modified":"2018-08-24T08:45:27","modified_gmt":"2018-08-24T12:45:27","slug":"calpers-health-chief-wields-the-power-of-data-to-tame-costs","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=11289","title":{"rendered":"CalPERS Health Chief Wields The Power Of Data To Tame Costs"},"content":{"rendered":"

(By Alex Leeds Matthews for California Healthline produced by Kaiser Health News)<\/p>\n

As prices for drugs and procedures soar, and health insurance premiums for\u00a0employer-based\u00a0and\u00a0individual policies\u00a0inexorably climb, more than are few people are asking: Is the health care industry spiraling out of control?<\/p>\n

Liana Bailey-Crimmins, a top official with California\u2019s public employee benefits and retirement system (CalPERS), offered a simple response. Continue reading the article here…<\/a><\/p>\n

This story was produced by Kaiser Health News, which publishes California Healthline, a service of the California Health Care Foundation.\u201d<\/p>\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n

\"\"<\/a><\/p>\n

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Alex Leeds Matthews for California Healthline produced by Kaiser Health News) As prices for drugs and procedures soar, and<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,15],"tags":[],"class_list":["post-11289","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11289"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11289\/revisions"}],"predecessor-version":[{"id":11290,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11289\/revisions\/11290"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}